arrow
返回
K

Kevin Horgan

AstraZeneca

34H指数
88论文数
1.1W被引数
收录论文 11
发表时间
Exposure-Response Analysis of Overall Survival for Tremelimumab in Unresectable Malignant Mesothelioma: The Confounding Effect of Disease Status
err2019-04-12
err16
errOAAI
errBaverel, Paul; Roskos, Lorin; Tatipalli, Manasa; Lee, Nancy; Stockman, Paul; Taboada, Maria; Vicini, Paolo; Horgan, Kevin; Narwal, Rajesh
err分享
err收藏
RENAL FUNCTION-BASED CONTRAST DOSING TO DEFINE 'PROGNOSTIC' CONTRAST LIMITS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
errHEART
IF4.4
err2018-01-25
err0
PREAI
errChandra, Navin; Nadra, Imad; Ding, Lillian; Hardiman, Sean; Fung, Anthony; Aymong, Eve; Webb, John; Wood, David; Virani, Sean; Chan, Albert W.; Vuurmans, Tycho; Hodge, Steven; Horgan, Kevin; Mawad, Habib; Levin, Adeera; Fretz, Eric; Robinson, Simon D.; Della Siega, Anthony; Iqbal, M. Bilal
err分享
err收藏
Exposure-efficacy (OS) analysis of tremelimumab in unresectable malignant mesothelioma
err2017-07-01
err0
PREAI
errBaverel, Paul; Roskos, Lorin; Tatipalli, Manasa; Lee, Nancy; Stockman, Paul; Taboada, Maria; Vicini, Paolo; Horgan, Kevin; Narwal, Rajesh
err分享
err收藏
IMO-2125 PLUS RIBAVIRIN GIVES SUBSTANTIAL FIRST-DOSE VIRAL LOAD REDUCTIONS, CUMULATIVE ANTI-VIRAL EFFECT, IS WELL TOLERATED IN NAIVE GENOTYPE1 HCV PATIENTS: A PHASE 1 TRIAL
err2011-03-01
err1
errOAAI
errGuyader, D.; Bogomolov, P.; Kobalava, Z.; Moiseev, V.; Szlavik, J.; Astruc, B.; Varkonyi, I.; Sullivan, T.; Horgan, K.; Bexon, A.; Arbeit, R.
err分享
err收藏
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
err2009-10-01
err472
errOAAI
errSandborn, William J.; Rutgeerts, Paul; Feagan, Brian G.; Reinisch, Walter; Olson, Allan; Johanns, Jewel; Lu, Jiandong; Horgan, Kevin; Rachmilewitz, Daniel; Hanauer, Stephen B.; Lichtenstein, Gary R.; de Villiers, Willem J. S.; Present, Daniel; Sands, Bruce E.; Colombel, Jean Frederic
err分享
err收藏
Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial
err2007-02-01
err55
errOAAI
errLanas, Angel; Baron, John A.; Sandler, Robert S.; Horgan, Kevin; Bolognese, Jim; Oxenius, Bettina; Quan, Hui; Watson, Douglas; Cook, Tomas J.; Schoen, Robert; Burke, Carol; Loftus, Susan; Niv, Yaron; Ridell, Robert; Morton, Dion; Bresalier, Robert
err分享
err收藏
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas
err2006-12-01
err388
errOAAI
errBaron, John A.; Sandler, Robert S.; Bresalier, Robert S.; Quan, Hui; Riddell, Robert; Lanas, Angel; Bolognese, James A.; Oxenius, Bettina; Horgan, Kevin; Loftus, Susan; Morton, Dion G.
err分享
err收藏
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
err2005-03-17
err2.1K
errOAAI
errBresalier, RS; Sandler, RS; Quan, H; Bolognese, JA; Oxenius, B; Horgan, K; Lines, C; Riddell, R; Morton, D; Lanas, A; Konstam, MA; Baron, JA
err分享
err收藏
Functional relevance of antiemetic control: experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant
err2003-07-01
err53
PREAI
errMartin, AR; Carides, AD; Pearson, JD; Horgan, K; Elmer, M; Schmidt, C; Cai, B; Chawla, SP; Grunberg, SM
err分享
err收藏